Frontlight ResearchEarly access
Trial site
ViDia Christliche Kliniken Karlsruhe
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Ovarian cancer3 trials
- Metastatic breast cancer2 trials
- Triple-negative breast cancer1 trial
- Phase
- Phase 33 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting1 trial
- Lead sponsor
- AGO Research GmbH2 trials
- AstraZeneca1 trial
- GBG Forschungs GmbH1 trial
- Prof. Wolfgang Janni1 trial
- University Hospital Tuebingen1 trial
Running trials
Recruiting
Active, not recruiting
Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer
Active, not recruiting
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer1 recruiting
Closed trials
Active, not recruiting
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026